Position statement: Nonanesthesiologist administration of propofol for GI endoscopy

John J. Vargo, Lawrence B. Cohen, Douglas K. Rex, Paul Y. Kwo

Research output: Contribution to journalReview article

13 Scopus citations

Abstract

This statement on the use of nonanesthesiologist-administered propofol (NAAP) for GI endoscopy is issued jointly by The American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy. A 4-member committee, composed of a representative from each society, prepared the first draft of this document, which was then reviewed and approved by the governing board of each organization. This document is designed to provide an evidence-based assessment of propofol-mediated sedation by properly trained gastroenterologists and other nonanesthesiologists. The safety, efficacy, cost-effectiveness, and training issues involved with nonanesthesiologist administration of propofol for GI endoscopy are reviewed, and a series of concluding statements and recommendations are provided. Whenever possible, these summary conclusions are graded based upon the strength of the supporting evidence (Table 1).

Original languageEnglish (US)
Pages (from-to)1683-1689
Number of pages7
JournalHepatology
Volume50
Issue number6
DOIs
StatePublished - Dec 1 2009

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Position statement: Nonanesthesiologist administration of propofol for GI endoscopy'. Together they form a unique fingerprint.

  • Cite this